Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Clinical trial NCT07544992 · RECRUITING

Trial details

NCT number

NCT07544992

Sponsor

City of Hope Medical Center

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2026-05-26

Primary completion

2031-11-04

Enrollment

24

View on ClinicalTrials.gov